ETS vs REGN · rev $726.8K vs P/E 14, rev $14.34B
Elite Express Holding Inc. Class A Common Stock (ETS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Elite Express Holding Inc. Class A Common Stock (ETS) is a trucking company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ETS revenue for 2026-05-31 was $726.8K. Net income was -$2.5M. Revenue was down 9.7% from 2026-02-28 to 2026-05-31. ETS currently screens at market cap $9.8M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ETS currently screens at market cap $9.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ETS and REGN stock pages for the full models.
Not investment advice.